SINGAPORE TRANSLATIONAL CANCER CONSORTIUM
Last Updated: 13 Apr 2026
The Consortium for Clinical Research and Innovation Singapore (CRIS) is a wholly owned subsidiary of MOH Holdings established in 2020 to strengthen synergies and promote strategies for national-level clinical research and translation programs under the stewardship of the Singapore Ministry of Health. CRIS brings together five entities as business units under a common management and governance structure, including the Singapore Clinical Research Institute (SCRI), the National Health Innovation Centre (NHIC), the Advanced Cell Therapy and Research Institute Singapore (ACTRIS), the Precision Health Research Singapore (PRECISE), and the Singapore Translational Cancer Consortium (STCC).
Country of registration | Singapore |
Registration number | 53408815E |
Local SIC | |
Incorporation date | 30 Jan 2020 |
Company age | 6 years 4 months |
Official entity type | Sole Proprietor |
No. of officers | 1 |
Contact
Address:
23 ROCHESTER PARK, #06-01, Singapore 139234
Access Key Decision Makers
This is the legal entity page of SINGAPORE TRANSLATIONAL CANCER CONSORTIUM. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- View MoreThe Consortium for Clinical Research and Innovation Singapore (CRIS) is a wholly owned subsidiary of MOH Holdings established in 2020 to strengthen synergies and promote strategies for national-level clinical research and translation programs under the stewardship of the Singapore Ministry of Health. CRIS brings together five entities as business units under a common management and governance structure, including the Singapore Clinical Research Institute (SCRI), the National Health Innovation Centre (NHIC), the Advanced Cell Therapy and Research Institute Singapore (ACTRIS), the Precision Health Research Singapore (PRECISE), and the Singapore Translational Cancer Consortium (STCC).
This is the legal entity page of SINGAPORE TRANSLATIONAL CANCER CONSORTIUM. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Revenue | 1 - 10m |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of SINGAPORE TRANSLATIONAL CANCER CONSORTIUM?
- Where is SINGAPORE TRANSLATIONAL CANCER CONSORTIUM's headquarter?
- What is SINGAPORE TRANSLATIONAL CANCER CONSORTIUM's contact number?
- What SINGAPORE TRANSLATIONAL CANCER CONSORTIUM's spending power?
- Does SINGAPORE TRANSLATIONAL CANCER CONSORTIUM have a presence in the domain it operates in?